Identification, diagnosis, and management of anemia in adult ambulatory patients treated by primary care physicians: evidence-based and consensus recommendations

References

• Ania BJ, Suman VJ, Fairbanks VF, et al. Prevalence of anemia in medical practice: community versus referral patients. Mayo Clin Proc 1994;69:730–5
   PubMed Web of Science ®Google Scholar
• Looker AC, Dallman PR, Carroll MD, et al. Prevalence of iron deficiency in the United States. JAMA 1997;277:973–6
   PubMed Web of Science ®Google Scholar
• Niederau C, Niederau CM, Lange S, et al. Screening for hemo-chromatosis and iron deficiency in employees and primary care patients in Western Germany. Ann Intern Med 1998;128:337–45
   PubMed Web of Science ®Google Scholar
• Van der Werf MJ, van Benthem BH, van Ameijden EJ. Prevalence, incidence and risk factors of anaemia in HIV-positive and HIV-negative drug users. Addiction 2000;95:383–92
   PubMed Web of Science ®Google Scholar
• Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352:1011–23
   PubMed Web of Science ®Google Scholar
• Guralnik JM, Eisenstaedt RS, Ferrucci L, et al. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 2004;104:2263–8
   PubMed Web of Science ®Google Scholar
• Goodnough LT, Dubois RW, Nissenson AR. Anemia: not just an innocent bystander? Arch Intern Med 2003;163:1400–4
   PubMed Web of Science ®Google Scholar
• Maeda K, Tanaka Y, Tsukano Y, et al. Multivariate analysis using a linear discriminant function for predicting the prognosis of congestive heart failure. Jpn Circ J 1982;46:137–42
   PubMedGoogle Scholar
• Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996;348:1055–60
   PubMed Web of Science ®Google Scholar
• Hebert PC, Wells G, Tweeddale M, et al. Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group. Am J Respir Crit Care Med 1997;155:1618–23
   PubMed Web of Science ®Google Scholar
• McClellan WM, Flanders WD, Langston RD, et al. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol 2002;13:1928–36
   PubMed Web of Science ®Google Scholar
• Silverberg DS, Wexler D, Sheps D, et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol 2001;37:1775–80
   PubMed Web of Science ®Google Scholar
• Wu WC, Rathore SS, Wang Y, et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001;345:1230–6
   PubMed Web of Science ®Google Scholar
• Foley RN, Parfrey PS, Morgan J. A randomized controlled trial of complete vs partial correction of anemia in hemodialysis patients with asymptomatic concentric LV hypertrophy or LV dilatation. Am Soc Nephrol 1998;9:208
   Google Scholar
• Levin A, Thompson CR, Ethier J, et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 1999;34:125–34
   PubMed Web of Science ®Google Scholar
• Collins AJ, Ma JZ, Ebben J. Impact of hematocrit on morbidity and mortality. Semin Nephrol 2000;20:345–9
   Google Scholar
• Low-Friedrich I, Grutzmacher P, Marz W, et al. Therapy with recombinant human erythropoietin reduces cardiac size and improves heart function in chronic hemodialysis patients. Am J Nephrol 1991;11:54–60
   Google Scholar
• Goldberg N, Lundin AP, Delano B, et al. Changes in left ventricular size, wall thickness, and function in anemic patients treated with recombinant human erythropoietin. Am Heart J 1992;124:424–7
   PubMed Web of Science ®Google Scholar
• Low I, Grutzmacher P, Bergmann M, et al. Echocardiographic findings in patients on maintenance hemodialysis substituted with recombinant human erythropoietin. Clin Nephrol 1989;31:26–30
   PubMed Web of Science ®Google Scholar
• NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-dialysis outcomes quality initiative. Am J Kidney Dis 1997;30:S192–240
   PubMedGoogle Scholar
• Rizzo JD, Lichtin AE, Woolf SH, et al. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. Blood 2004;100:2303–20
   Web of Science ®Google Scholar
• U.S. Department of Health and Human Services. Healthy people 2010: understanding and improving health. 2nd edn. Washington DC, U.S. Government Printing Office, 2000
   Google Scholar
• Fitch K, Bernstein SJ, Aguilar MD, et al. The RAND/UCLA appropriateness method user’s manual. Santa Monica, CA: RAND; 2001
   Google Scholar
• Kravitz RL, Laouri M, Kahan JP, et al. Validity of criteria used for detecting underuse of coronary revascularization. JAMA 1995;274:632–8
   PubMed Web of Science ®Google Scholar
• Shekelle PG, Kahan JP, Bernstein SJ, et al. The reproducibility of a method to identify the overuse and underuse of medical procedures. N Engl J Med 1998;338:1888–95
   PubMed Web of Science ®Google Scholar
• Joosten E, Pelemans W, Hiele M, et al. Prevalence and causes of anaemia in a geriatric hospitalized population. Gerontology 1992;38:111–7
   PubMed Web of Science ®Google Scholar
• Sullivan PS, Hanson DL, Chu SY, et al. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood 1998;91:301–8
   PubMed Web of Science ®Google Scholar
• Ania BJ, Suman VJ, Fairbanks VF, et al. Prevalence of anemia in medical practice: community versus referral patients. Mayo Clin Proc 1994;69:730–5
   PubMed Web of Science ®Google Scholar
• Salive ME, Cornoni-Huntley J, Guralnik JM, et al. Anemia and hemoglobin levels in older persons: relationship with age, gender, and health status. J Am Geriatr Soc 1992;40:489–96
   PubMed Web of Science ®Google Scholar
• Nilsson-Ehle H, Jagenburg R, Landahl S, et al. Haematological abnormalities and reference intervals in the elderly. A cross-sectional comparative study of three urban Swedish population samples aged 70, 75 and 81 years. Acta Med Scand 1988;224: 595–604
   Google Scholar
• De Craen AJ, Gussekloo J, Teng YK, et al. Prevalence of five common clinical abnormalities in very elderly people: population based cross sectional study. BMJ 2003;327:131–2
   PubMed Web of Science ®Google Scholar
• Silverberg DS, Wexler D, Blum M, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 2000;35:1737–44
   PubMed Web of Science ®Google Scholar
• Baer AN, Dessypris EN, Krantz SB. The pathogenesis of anemia in rheumatoid arthritis: a clinical and laboratory analysis. Semin Arthritis Rheum 1990;19:209–23
   Web of Science ®Google Scholar
• De Marchi S, Pirisi M, Ferraccioli GF. Erythropoietin and the anemia of chronic diseases. Clin Exp Rheumatol 1993;11:429–44
   PubMedGoogle Scholar
• Schreiber S, Howaldt S, Schnoor M, et al. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N Engl J Med 1996;334:619–23
   PubMed Web of Science ®Google Scholar
• Semba RD, Shah N, Klein RS, et al. Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women. Clin Infect Dis 2002;34:260–6
   PubMed Web of Science ®Google Scholar
• Semba RD, Shah N, Klein RS, et al. Highly active antiretroviral therapy associated with improved anemia among HIV-infected women. AIDS Patient Care STDS 2001;15:473–80
   PubMed Web of Science ®Google Scholar
• Semba RD, Shah N, Vlahov D. Improvement of anemia among HIV-infected injection drug users receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2001;26:315–9
   Google Scholar
• Bothwell T. The importance of assessing iron status. Hosp Pract (Off Ed) 1991;26(Suppl 3):11–6
   PubMedGoogle Scholar
• Gordon SR, Smith RE, Power GC. The role of endoscopy in the evaluation of iron deficiency anemia in patients over the age of 50. Am J Gastroenterol 1994;89: 1963–7
   Google Scholar
• Sari R, Aydogdu I, Sevinc A, et al. Upper and lower gastro-intestinal endoscopical investigation in elderly patients with iron deficiency anaemia. Haematologia (Budap) 2002;31:327–32
   PubMedGoogle Scholar
• Beveridge BR, Bannerman RM, Evanson JM, et al. Hypochromic anaemia. A retrospective study and follow-up of 378 in-patients. Q J Med 1965;34: 145–61
   Google Scholar
• Kirkeby OJ, Fossum S, Risoe C. Anaemia in elderly patients. Incidence and causes of low haemoglobin concentration in a city general practice. Scand J Prim Health Care 1991;9:167–71
   Google Scholar
• Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997;89:1052–7
   Google Scholar
• Guyatt GH, Patterson C, Ali M, et al. Diagnosis of iron-deficiency anemia in the elderly. Am J Med 1990;88:205–9
   PubMed Web of Science ®Google Scholar
• Remacha AF, Rodriguez-de la Serna A, Garcia-Die F, et al. Erythroid abnormalities in rheumatoid arthritis: the role of erythropoietin. J Rheumatol 1992;19:1687–91
   Google Scholar
• Peeters HR, Jongen-Lavrencic M, Raja AN, et al. Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onset. Ann Rheum Dis 1996;55:162–8
   PubMed Web of Science ®Google Scholar
• Izaks GJ, Westendorp RG, Knook DL. The definition of anemia in older persons. JAMA 1999;281:1714–17
   Google Scholar
• Moore RD, Keruly JC, Chaisson RE. Anemia and survival in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1998;19:29–33
   PubMedGoogle Scholar
• Linde T, Wikstrom B, Andersson LG, et al. Renal anaemia treatment with recombinant human erythropoietin increases cardiac output in patients with ischaemic heart disease. Scand J Urol Nephrol 1996;30:115–20
   PubMed Web of Science ®Google Scholar
• Peeters HR, Jongen-Lavrencic M, Bakker CH, et al. Recombinant human erythropoietin improves health-related quality of life in patients with rheumatoid arthritis and anaemia of chronic disease; utility measures correlate strongly with disease activity measures. Rheumatol Int 1999;18:201–6
   PubMed Web of Science ®Google Scholar
• Gasche C, Dejaco C, Waldhoer T, et al. Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial. Ann Intern Med 1997;126:782–7
   PubMed Web of Science ®Google Scholar
• Kaltwasser JP, Kessler U, Gottschalk R, et al. Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis. J Rheumatol 2001;28:2430–6
   PubMed Web of Science ®Google Scholar
• DeMaeyer E, Adiels-Tegman M. The prevalence of anaemia in the world. World Health Stat Q 1985;38:302–16
   PubMedGoogle Scholar
• Adams PF, Hendershot GE, Marano MA. Current estimates from the National Health Interview Survey, 1996. National Center for Health Statistics. Vital Health Stat 1999;10: 1–203
   Google Scholar
• Park RE, Fink A, Brook RH, et al. Physician ratings of appropriate indications for three procedures: theoretical indications vs indications used in practice. Am J Public Health 1989;79:445–7
   PubMed Web of Science ®Google Scholar